Braun Bostich & Associates Inc. Abb Vie Inc. Transaction History

Braun Bostich & Associates Inc.

$140 Million
Q3 2024

A detailed history of Braun Bostich & Associates Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Braun Bostich & Associates Inc. holds 1,671 shares of ABBV stock, worth $302,684. This represents 0.24% of its overall portfolio holdings.

Number of Shares

1,671

Previous 1,764 5.27%

Holding current value

$302,684

Previous $302,000 8.94%

% of portfolio

0.24%

Previous 0.23%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $15,237 - $18,537	-93 Reduced 5.27%	1,671 $329,000
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $3,869 - $4,519	25 Added 1.44%	1,764 $302,000
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $51,462 - $58,636	-322 Reduced 15.62%	1,739 $316,000
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $283,593 - $319,393	2,061 New	2,061 $319,000
Q2 2023 Jul 25, 2023	BUY	$132.51 - $164.9 $55,521 - $69,093	419 Added 24.71%	2,115 $284,000
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $56,831 - $65,450	393 Added 30.16%	1,696 $270,000
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $180,217 - $216,128	1,303 New	1,303 $210,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $194,544 - $262,655	-2,417 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $173,538 - $203,676	-2,020 Reduced 45.53%	2,417 $212,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $3,154 - $4,221	43 Added 0.98%	4,437 $436,000
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $162,733 - $246,724	2,523 Added 134.85%	4,394 $323,000
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $134,955 - $168,857	1,871 New	1,871 $168,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $255,635 - $307,347	-4,059 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $123,056 - $157,294	-1,873 Reduced 31.57%	4,059 $295,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $64,411 - $75,809	-835 Reduced 12.34%	5,932 $478,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $451,140 - $556,377	5,795 Added 596.19%	6,767 $624,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $39,831 - $44,280	448 Added 85.5%	972 $92,000
Q1 2018 May 16, 2018	SELL	$92.01 - $123.21 $46,925 - $62,837	-510 Reduced 49.32%	524 $0
Q4 2017 May 21, 2018	BUY	$89.56 - $98.21 $92,605 - $101,549	1,034	1,034 $100,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Braun Bostich & Associates Inc. with notifications on news.

Account

Braun Bostich & Associates Inc. Abb Vie Inc. Transaction History